ArticleiScience2026
Clinical 2D MRI radiomics for infant brain age and trajectory modeling.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clinical 2D magnetic resonance imaging (MRI) is the cornerstone for assessing early brain development, yet the lack of a systematic methodology renders the fine-grained and quantitative evaluation of early brain growth underdeveloped. We address this gap using a data-driven radiomics framework that integrates automatic registration, segmentation, and feature extraction for the analysis of 2,893 routine T1-weighted and T2-weighted scans from children aged 0-2 years. The framework yields accurate brain age prediction (mean absolute error = 1.19 months) and pinpoints the "corpus callosum median" (CC-median) as the most critical, biologically relevant predictor. We used the generalized additive model for location, scale, and shape (GAMLSS) to model the normative trajectory of CC-median. This standardized curve robustly differentiates developmental delays from typical peers, achieving an accuracy of 0.96 (for ages 6-24 months). This work establishes a clinically compatible framework, transforming conventional 2D MRI data into a powerful, objective tool for early neurodevelopmental assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.